Pharma News

The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics, opens new tab treatment for dry eye disease, the company said on Thursday, sending its shares down 73%...

The European Commission (EC) has approved Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) for use as a single agent to treat adults with unresectable or metastatic ...

A government-funded research team has identified focal adhesion kinase (FAK) as a key driver of melanoma metastasis to the brain.

BIIB080 is the first tau-targeting antisense oligonucleotide therapy to reach clinical trials for Alzheimer's disease. Phase 1b trials showed positive cognitive trends and reduced tau protein leve...

Scientists have developed a new transgene control system that shows early promise for treating rare brain disorder Rett syndrome.

Neoadjuvant Darovasertib Receives FDA Breakthrough Therapy Designation for Uveal melanoma

Accord Healthcare Receives Positive CHMP Opinion for Denosumab, Osvyrti®, and Jubereq®

FDA Grants Orphan Drug Designation for MDS to Investigational CLEVER-1-Targeting Immunotherapy

People with low LDL cholesterol levels are much less likely to be diagnosed with dementia and Alzheimer’s disease, according to new research.

Subtle cognitive deficits identified in preclinical stages of Alzheimer’s that could improve early diagnosis and treatment

The number of late-stage drug candidates with peak sales forecasts exceeding $1bn rose significantly last year, buoyed in part by the lucrative weight loss and diabetes markets, analysis shows. GLP-1R...

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025